Yoav H Messinger MD

Pediatric Hematology & Oncology•St. Paul, MN

Pediatric Hematologist/Oncologist Children's Hospitals of Minnesota

347 Smith Ave NSt. Paul, MN 55102
Phone+1 651-220-6732
Fax+1 651-220-6005

Dr. Messinger is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Messinger's full profile Already have an account?

Education & Training

University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1993 - 1996
University of MinnesotaResidency, Pediatrics, 1991 - 1993
Tel Aviv University SacklerClass of 1985

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MN State Medical License 1993 - 2027
WI State Medical License 2011 - 2023

Clinical Trials

Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL) Start of enrollment: 2006 Aug 04
COMPLETED
PHASE1, PHASE2
Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome
COMPLETED
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
TERMINATED
PHASE1, PHASE2

Publications & Presentations

PubMed

Bortezomib and vorinostat in combination with mitoxantrone, dexamethasone, and pegasparaginase during induction and reinduction for infants with acute lymphoblastic le...
Tanja A Gruber, Sima Jeha, Rebecca J Deyell, Victor Lewis, Bill H Chang
The Lancet. Haematology. 2026-03-01
1 citations
RAS pathway targeted therapy in patients with DICER1-associated sarcomas.
Lindy Zhang, Paige H R Mallinger, Serena Zhou, Stavriani C Makri, John M Gross
NPJ Precision Oncology. 2025-07-09
2 citations
Ovarian juvenile granulosa cell tumor: A report from the International Ovarian and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/DICER1 Registries.
Anne K Harris, Alexander T Nelson, Dave Watson, Paige H R Mallinger, Yoav H Messinger
Cancer. 2025-05-01